“Sodium Thiosulfate’s Lack of Effect on Infarct Size and Clinical Outcomes in First ST-Segment Elevation Myocardial Infarction: A Randomized Clinical Trial”

https://pubmed.ncbi.nlm.nih.gov/38094689

This randomized clinical trial found that sodium thiosulfate, a potent antioxidant, did not reduce infarct size or improve clinical outcomes in patients with a first ST-segment elevation myocardial infarction.